Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (7): 696-699.DOI: 10.3969/j.issn.1673-8640.2024.07.013
Previous Articles Next Articles
Received:
2024-01-16
Revised:
2024-05-25
Online:
2024-07-30
Published:
2024-07-31
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2024.07.013
试剂名称 | R①/min | K②/min | α③/° | MA/mm |
---|---|---|---|---|
1#FF-10 μL | 0.8 | N/A | 48.5±1.1 | 14.4±0.5 |
2#FF-10 μL | 0.8 | N/A | 48.5±1.0 | 14.4±0.7 |
3#FF-10 μL | 0.7 | N/A | 54.0±1.4 | 13.8±0.9 |
4#FF-10 μL | 0.6 | N/A | 59.6±1.3 | 14.8±0.7 |
3#FF-20 μL | 0.5 | N/A | 54.3±1.1 | 10.7±0.5 |
4#FF-20 μL | 0.6 | N/A | 55.5±1.3 | 10.6±0.4 |
试剂名称 | R①/min | K②/min | α③/° | MA/mm |
---|---|---|---|---|
1#FF-10 μL | 0.8 | N/A | 48.5±1.1 | 14.4±0.5 |
2#FF-10 μL | 0.8 | N/A | 48.5±1.0 | 14.4±0.7 |
3#FF-10 μL | 0.7 | N/A | 54.0±1.4 | 13.8±0.9 |
4#FF-10 μL | 0.6 | N/A | 59.6±1.3 | 14.8±0.7 |
3#FF-20 μL | 0.5 | N/A | 54.3±1.1 | 10.7±0.5 |
4#FF-20 μL | 0.6 | N/A | 55.5±1.3 | 10.6±0.4 |
编号 | 1个月 | 2个月 | 3个月 | 6个月 | 9个月 | 12个月 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | |
171101 | 17.0~21.3 | 8.8 | 17.4~23.0 | 9.7 | 16.7~19.9 | 6.3 | 19.2~21.9 | 4.4 | 17.1~21.4 | 6.9 | 17.6~20.4 | 4.8 |
171201 | 18.9~22.5 | 6.2 | 18.1~21.2 | 5.2 | 17.3~20.5 | 6.2 | 17.8~23.0 | 7.8 | 16.9~19.5 | 5.3 | 16.9~21.4 | 7.9 |
171202 | 17.5~22.2 | 7.3 | 19.0~21.9 | 5.1 | 18.4~22.3 | 5.5 | 17.8~22.9 | 7.9 | 19.1~22.5 | 4.9 | 17.6~20.2 | 4.4 |
编号 | 15个月 | 18个月 | 21个月 | 24个月 | 26个月 | |||||||
检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | |||
171101 | 17.6~21.1 | 5.5 | 17.1~22.0 | 6.6 | 20.1~24.8 | 7.6 | 16.0~20.0 | 8 | 15.3~19.8 | 8.4 | ||
171201 | 16.5~21.4 | 8.8 | 18.5~21.7 | 5.8 | 20.3~22.5 | 3.7 | 17.8~20.5 | 4.2 | 15.3~18.5 | 5.6 | ||
171202 | 17.4~22.3 | 7.4 | 18.4~21.9 | 5.3 | 20.0~23.0 | 4.5 | 16.0~24.3 | 11.5 | 17.1~19.7 | 4.7 |
编号 | 1个月 | 2个月 | 3个月 | 6个月 | 9个月 | 12个月 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | |
171101 | 17.0~21.3 | 8.8 | 17.4~23.0 | 9.7 | 16.7~19.9 | 6.3 | 19.2~21.9 | 4.4 | 17.1~21.4 | 6.9 | 17.6~20.4 | 4.8 |
171201 | 18.9~22.5 | 6.2 | 18.1~21.2 | 5.2 | 17.3~20.5 | 6.2 | 17.8~23.0 | 7.8 | 16.9~19.5 | 5.3 | 16.9~21.4 | 7.9 |
171202 | 17.5~22.2 | 7.3 | 19.0~21.9 | 5.1 | 18.4~22.3 | 5.5 | 17.8~22.9 | 7.9 | 19.1~22.5 | 4.9 | 17.6~20.2 | 4.4 |
编号 | 15个月 | 18个月 | 21个月 | 24个月 | 26个月 | |||||||
检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | |||
171101 | 17.6~21.1 | 5.5 | 17.1~22.0 | 6.6 | 20.1~24.8 | 7.6 | 16.0~20.0 | 8 | 15.3~19.8 | 8.4 | ||
171201 | 16.5~21.4 | 8.8 | 18.5~21.7 | 5.8 | 20.3~22.5 | 3.7 | 17.8~20.5 | 4.2 | 15.3~18.5 | 5.6 | ||
171202 | 17.4~22.3 | 7.4 | 18.4~21.9 | 5.3 | 20.0~23.0 | 4.5 | 16.0~24.3 | 11.5 | 17.1~19.7 | 4.7 |
编号 | 1个月 | 2个月 | 3个月 | 6个月 | 9个月 | 12个月 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | |
171101 | 33.5~40.0 | 6.5 | 35.7~40.7 | 3.8 | 34.5~40.3 | 4.8 | 34.8~40.4 | 4.5 | 35.7~38.9 | 2.3 | 36.3~41.5 | 4.2 |
171201 | 35.9~39.9 | 3.2 | 34.6~40.0 | 4.6 | 36.1~40.2 | 3.4 | 36.5~40.3 | 3.2 | 35.4~40.7 | 4.3 | 37.7~41.2 | 2.7 |
171202 | 26.8~40.1 | 2.7 | 36.0~40.0 | 3.1 | 35.2~40.0 | 4.4 | 37.5~41.1 | 3.1 | 35.8~38.7 | 2.7 | 36.9~42.9 | 4.3 |
编号 | 15个月 | 18个月 | 21个月 | 24个月 | 26个月 | |||||||
检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | |||
171101 | 35.9~41.4 | 4.5 | 36.0~40.4 | 3.9 | 35.7~40.4 | 4.6 | 34.0~38.8 | 4.3 | 33.9~40.6 | 5.3 | ||
171201 | 37.4~39.9 | 2.6 | 35.8~39.0 | 3.3 | 35.6~39.8 | 4.9 | 34.8~37.9 | 2.8 | 36.7~40.3 | 3.3 | ||
171202 | 35.4~39.2 | 3.4 | 36.3~41.2 | 3.6 | 36.0~39.9 | 3.6 | 30.1~39.6 | 7.2 | 36.9~40.0 | 3.2 |
编号 | 1个月 | 2个月 | 3个月 | 6个月 | 9个月 | 12个月 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | |
171101 | 33.5~40.0 | 6.5 | 35.7~40.7 | 3.8 | 34.5~40.3 | 4.8 | 34.8~40.4 | 4.5 | 35.7~38.9 | 2.3 | 36.3~41.5 | 4.2 |
171201 | 35.9~39.9 | 3.2 | 34.6~40.0 | 4.6 | 36.1~40.2 | 3.4 | 36.5~40.3 | 3.2 | 35.4~40.7 | 4.3 | 37.7~41.2 | 2.7 |
171202 | 26.8~40.1 | 2.7 | 36.0~40.0 | 3.1 | 35.2~40.0 | 4.4 | 37.5~41.1 | 3.1 | 35.8~38.7 | 2.7 | 36.9~42.9 | 4.3 |
编号 | 15个月 | 18个月 | 21个月 | 24个月 | 26个月 | |||||||
检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | 检测值/mm | CV/% | |||
171101 | 35.9~41.4 | 4.5 | 36.0~40.4 | 3.9 | 35.7~40.4 | 4.6 | 34.0~38.8 | 4.3 | 33.9~40.6 | 5.3 | ||
171201 | 37.4~39.9 | 2.6 | 35.8~39.0 | 3.3 | 35.6~39.8 | 4.9 | 34.8~37.9 | 2.8 | 36.7~40.3 | 3.3 | ||
171202 | 35.4~39.2 | 3.4 | 36.3~41.2 | 3.6 | 36.0~39.9 | 3.6 | 30.1~39.6 | 7.2 | 36.9~40.0 | 3.2 |
放置时间 | R/min | K/min | α角/° | MA/mm | 与2 h 时MA检测结果的偏差/% |
---|---|---|---|---|---|
2 h | 0.7 | 2.8±0.2 | 77.5±0.5 | 22.6±0.8 | |
10 h | 0.6 | 3.2±0.2 | 77.0±0.6 | 20.8±0.9 | -7.96 |
24 h | 0.7 | 3.2±0.1 | 77.3±0.5 | 22.5±0.8 | -0.44 |
34 h | 0.7 | 2.5±0.2 | 77.9±0.4 | 23.1±0.7 | 2.21 |
48 h | 0.8 | 4.8±0.3 | 76.2±0.3 | 21.6±0.8 | -4.42 |
54 h | 0.6 | 7.0±0.4 | 75.8±0.6 | 20.6±0.9 | -8.85 |
60 h | 0.6 | 无结果 | 74.5±0.5 | 19.4±0.6 | -14.16 |
放置时间 | R/min | K/min | α角/° | MA/mm | 与2 h 时MA检测结果的偏差/% |
---|---|---|---|---|---|
2 h | 0.7 | 2.8±0.2 | 77.5±0.5 | 22.6±0.8 | |
10 h | 0.6 | 3.2±0.2 | 77.0±0.6 | 20.8±0.9 | -7.96 |
24 h | 0.7 | 3.2±0.1 | 77.3±0.5 | 22.5±0.8 | -0.44 |
34 h | 0.7 | 2.5±0.2 | 77.9±0.4 | 23.1±0.7 | 2.21 |
48 h | 0.8 | 4.8±0.3 | 76.2±0.3 | 21.6±0.8 | -4.42 |
54 h | 0.6 | 7.0±0.4 | 75.8±0.6 | 20.6±0.9 | -8.85 |
60 h | 0.6 | 无结果 | 74.5±0.5 | 19.4±0.6 | -14.16 |
[1] | 施城东, 樊卫, 张娟, 等. 血小板聚集功能、血液黏度及纤维蛋白原检测在急性脑梗死中的临床意义[J]. 中国临床研究, 2022, 35(11):1605-1608. |
[2] | 马平, 褚锋. 血浆血栓弹力图与纤维蛋白原及D-二聚体检测对恶性肿瘤患者凝血功能评估的临床价值[J]. 现代检验医学杂志, 2020, 35(2):72-75. |
[3] | 黄海云, 陈峻. 慢性肾功能衰竭患者血浆D-二聚体纤维蛋白原凝血酶原时间及活化部分凝血活酶时间检测的临床价值[J]. 实用医技杂志, 2015, 22(12):1302-1303. |
[4] | 林壮琼, 张展青. 肝硬化患者凝血功能和血小板检测分析[J]. 检验医学与临床, 2013, 10(8):986-987. |
[5] |
缪颖波, 赵强, 宋颖, 等. 血栓弹力图性能规范研究[J]. 检验医学, 2022, 37(7):680-683.
DOI |
[6] | 国家食品药品监督管理总局. 生物制品稳定性研究技术指导原则(试行)[EB/OL].(2015-04-15) [2023-12-01]. http://www.sda.gov.cn/WS01/CL0087/117440.html . |
[7] | Clinical and Laboratory Standards Institution. Defining, establishing, and verifying reference intervals in the clinical laboratory[S]. C28-A3,CLSI, 2008. |
[8] | RANUCCI M, DI DEDDA U, BARYSHNIKOVA E. Trials and tribulations of viscoelastic-based determination of fib rinogen concentration[J]. Anesth Analg, 2020, 130(3):644-653. |
[9] | 田榆, 张茜. 血栓弹力图的临床应用[J]. 临床医学研究与实践, 2017, 2(12):9-10. |
[1] | WANG Tiankai, LIU Lin, JIN Peipei, WANG Fang, DING Ning. Clinical value of new neutrophil parameter NEU-X,NEU-Y and NEU-Z in diagnosis of sepsis [J]. Laboratory Medicine, 2024, 39(7): 682-686. |
[2] | ZHAO Chunhe, SHAO Huihui, CUI Weiqi, XIA Wei, QU Linlin. Progress in application of blood coagulation point-of-care testing [J]. Laboratory Medicine, 2024, 39(7): 709-714. |
[3] | . [J]. Laboratory Medicine, 2024, 39(6): 602-607. |
[4] | ZHOU Ruiling, ZHANG Xinyu, REN Xiaoling, ZHANG Wen, FAN Changzheng, ZHANG Qiong. Relationship between uric acid/creatinine ratio and neutrophil/lymphocyte ratio and hypoxemia in patients with acute exacerbation of chronic obstructive pulmonary disease [J]. Laboratory Medicine, 2024, 39(5): 474-479. |
[5] | LI Kejing, WANG Lin, YANG Ning. Relationship between NLR,TGF-β1 and Cav-1 levels and bleeding risk after mechanical thrombectomy for acute intracranial artery occlusion in elders [J]. Laboratory Medicine, 2024, 39(5): 480-484. |
[6] | LIU Lin, WANG Tiankai, QIN Kangchunfeng, DING Ning. Correlations between monocyte-to-lymphocyte ratio with coronary heart disease and the extent of coronary atherosclerosis [J]. Laboratory Medicine, 2024, 39(5): 485-490. |
[7] | WANG Xuexing, CHEN Chunmei, HE Yuan, CHU Jie, WEI Chunmei. Roles of thromboelastography and coagulation index in predicting venous thromboembolism in patients with tumors [J]. Laboratory Medicine, 2024, 39(5): 491-496. |
[8] | XIONG Tianhui, CHAI Kening, XIA Wei, QU Linlin. Research progress of rivaroxaban causing changes in platelet count and function [J]. Laboratory Medicine, 2024, 39(5): 504-509. |
[9] | . [J]. Laboratory Medicine, 2024, 39(5): 513-516. |
[10] | HUANG Lei, TANG Wenjia, ZHOU Yan, ZHOU Jiaye, ZHANG Chunyan, YANG Jing, WANG Beili, PAN Baishen, GUO wei. Prognosis of RDW-SD and RDW-CV in breast cancer patients with lymphatic metastasis [J]. Laboratory Medicine, 2024, 39(4): 376-381. |
[11] | . [J]. Laboratory Medicine, 2024, 39(1): 68-70. |
[12] | DENG Chenxia, MEI Yanping, ZHANG Xia, HUANG Baoshan, TIAN Dan, CAO Mengting, HU Yongqi, LIN Yongping, TIAN Lijun. Depolymerization effect of optical platelet count on reversible platelet aggregation after blood collection [J]. Laboratory Medicine, 2023, 38(11): 1087-1090. |
[13] | LU Tingyan, GU Danfeng, WANG Yahong, GE Yafang, YANG Haiou. Evaluation of vaginal secretion routine determination modes and review criteria analysis [J]. Laboratory Medicine, 2023, 38(11): 1091-1097. |
[14] | . [J]. Laboratory Medicine, 2023, 38(11): 1098-1100. |
[15] | . [J]. Laboratory Medicine, 2023, 38(10): 983-986. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||